ArticleOncotarget2017

CD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer.

Mizuho Sato-Dahlman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.